🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.05
-0.07 (-0.98%)
Nov 20, 2026, 4:00 PM EST - Market closed

Puma Biotechnology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
231.83228.37230.47235.64228.03253.16
Revenue Growth
9.35%-0.91%-2.19%3.34%-9.92%12.46%
Cost of Revenue
61.2258.1664.462.6855.0963.7
Gross Profit
170.6170.21166.06172.96172.94189.45
Selling, General & Admin
70.6570.8580.1689.9389.98116.29
Research & Development
73.8162.0754.9450.3852.2471.87
Operating Expenses
144.46132.92135.1140.32142.22188.16
Operating Income
26.1437.330.9732.6430.721.29
Interest Expense
-2.03-6.62-12.45-13.33-11.59-12.81
Interest & Investment Income
3.694.084.722.610.810.16
Other Non Operating Income (Expenses)
0.31.030.860.76-0.030.29
EBT Excluding Unusual Items
28.135.7824.122.6719.91-11.07
Legal Settlements
-----12.46-9.59
Other Unusual Items
------8.15
Pretax Income
28.135.7824.122.670.46-28.8
Income Tax Expense
4.274.67-6.181.080.460.32
Net Income
23.8331.1130.2821.590-29.13
Net Income to Common
23.8331.1130.2821.590-29.13
Net Income Growth
-35.56%2.75%40.23%1079450.00%--
Shares Outstanding (Basic)
515049474541
Shares Outstanding (Diluted)
525149484541
Shares Change
4.54%3.16%3.26%5.83%10.56%2.69%
EPS (Basic)
0.470.620.620.460.00-0.72
EPS (Diluted)
0.450.610.620.450.00-0.72
EPS Growth
-38.91%-1.61%37.78%1022625.00%--

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
46.0741.7338.8626.87-15.8320.65
Free Cash Flow Per Share
0.880.820.790.56-0.350.51
Gross Margin
73.59%74.53%72.06%73.40%75.84%74.84%
Operating Margin
11.27%16.33%13.44%13.85%13.47%0.51%
Profit Margin
10.28%13.62%13.14%9.16%0.00%-11.51%
Free Cash Flow Margin
19.87%18.27%16.86%11.40%-6.94%8.16%
EBITDA
35.5547.4441.0942.8640.5612.6
EBITDA Margin
15.33%20.77%17.83%18.19%17.79%4.98%
D&A For EBITDA
9.4110.1410.1210.229.8411.31
EBIT
26.1437.330.9732.6430.721.29
EBIT Margin
11.27%16.33%13.44%13.85%13.47%0.51%
Effective Tax Rate
15.19%13.05%-4.78%99.56%-
Revenue as Reported
231.83228.37230.47235.64228.03253.16
SEC Filings: 10-K · 10-Q